Skip to main content
Hajj And Omrah
About SFDA
About SFDA
نظرة عامة
Authority Establishment
Authority Membership
Authority Activities
Authority Management
Board of directors
SFDA in vision 2030
Vision Realization Office
National Transformation Program
Health Sector Transformation Program
National Industrial Development and Logistics Program
Authority Strategy
Strategy
Authority Values
Annual Reports
Career and Life
Life in SFDA
Career General Goals
Information Lists
All
The Authority
Food
Drugs
Medical Devices
الأعلاف
Pesticides
Laboratories
Cosmetics
Tobacco
Halal
Nutrition
Areas
All
The Authority
Food
Drugs
Medical Devices
الأعلاف
Pesticides
Laboratories
Cosmetics
Tobacco
Halal
Nutrition
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
نظرة عامة
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Evaluation Program
Decisions
نظرة عامة
Laws and Regulations
Guidelines
Drugs Circulars
forms
Circulars
FAQ
Sector Committee
نظرة عامة
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Studies and Research
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
نظرة عامة
Laws and Regulations
Guidelines
Forms
Circulars
FAQ
نظرة عامة
Scientific reports and statements
Laws and Regulations
Guidelines
Consumer Corner
Awareness Campaign
Topics of Interest
Interactive calculators
Media Centre
News
Rumours
Warnings
Events
Workshops
ميديا
Podcasts
Forms
Scientific Magazines And Articles
Eservices
All
The Authority
Food
Drugs
Medical Devices
الأعلاف
Pesticides
Laboratories
Cosmetics
Tobacco
Halal
Nutrition
Font Resize
+A
A
-A
Contrast
عربي
Hajj And Omrah
About SFDA
About SFDA
نظرة عامة
Authority Establishment
Authority Membership
Authority Activities
Authority Management
Board of directors
SFDA in vision 2030
Vision Realization Office
National Transformation Program
Health Sector Transformation Program
National Industrial Development and Logistics Program
Authority Strategy
Strategy
Authority Values
Annual Reports
Career and Life
Life in SFDA
Career General Goals
Information Lists
All
The Authority
Food
Drugs
Medical Devices
الأعلاف
Pesticides
Laboratories
Cosmetics
Tobacco
Halal
Nutrition
Areas
All
The Authority
Food
Drugs
Medical Devices
الأعلاف
Pesticides
Laboratories
Cosmetics
Tobacco
Halal
Nutrition
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
نظرة عامة
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Evaluation Program
Decisions
نظرة عامة
Laws and Regulations
Guidelines
Drugs Circulars
forms
Circulars
FAQ
Sector Committee
نظرة عامة
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Studies and Research
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
نظرة عامة
Laws and Regulations
Guidelines
Forms
Circulars
FAQ
نظرة عامة
Scientific reports and statements
Laws and Regulations
Guidelines
Consumer Corner
Awareness Campaign
Topics of Interest
Interactive calculators
Media Centre
News
Rumours
Warnings
Events
Workshops
ميديا
Podcasts
Forms
Scientific Magazines And Articles
Eservices
All
The Authority
Food
Drugs
Medical Devices
الأعلاف
Pesticides
Laboratories
Cosmetics
Tobacco
Halal
Nutrition
Home
Search Results
Containing any of the words
Only of the type
All
Awareness Article
List Registered Pharmacies
Annual Report
Awareness Campaign
calculators
Conference
Cosmetics Warning
Drug evaluation reports
Drug Membership
Drug Safety Labeling
Eservices
Event
Events
Excellent establishments list
Hajj card
HAPC Committee Decisions
head of board
hpac-members
International Standard
Laboratories
Lists
List Drugs Withdrawal
List of hospital that reported sides effects
List Registered Drugs
Marketed Products
Periodic Safety
portables service
Regulations exceptions
Risk Minimization Activity
Scientific reports and statement
sector committee
Sector Committee decisions
service providing facilities
Speakers
Standard
Standards Projects For Medical Devices
Surveys
test
Vaccine Safety
Warehouse
Circulars
Clinical Trial
Cosmetics standards Project
covid pages
Drug Clinical Trial
Drug Log
Forms
Information List
List Shortage Drug
List Under registration Drugs / Under committee review
Medical devices studies
Medical Report
Message
News
New SFDA Drug Approvals
Open Data
Podcasts
Reference repositories drugs
Risk Minimization Activity - New
Rumours
Safety Alert
Scientific Magazines and articles
Warnings
A randomized, double-blinded placebo-controlled, phase 3, parallel-group design study evaluating the efficacy and safety of Efgartigimod PH20 SC Administered by prefilled syringe in adults participants with ocular MG
Drug Clinical Trial
An Open label, Single Center, prospective interventional, phase II clinical trial to evaluate the Efficacy and Safety of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine(BV-AVD) combination escalation in advanced stage classical Hodgkin lymphoma patients who did not achieve interim Positron Emission Tomography (PET2) negativity (defined as Deauville score 3 or less) after 2 cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine (ABVD)
Drug Clinical Trial
AVEIR™ Leadless Pacemaker Registry in Europe and Middle East Region
Clinical Trial
GHWP Leaders Decide to Support Less Regulated Countries to Increase their Medical Devices Efficiency
News
SFDA Declares that Samples of Similac Gain Plus 3 Infant Milk Powder are free from contamination
Warnings
SFDA Recognized as a Leader in Risk Management and Business Continuity in "Qiyas 2025" Index
News
(SG-1912-167-H) Contact between electrode and defibrillator may be interrupted
Medical Report
(SG-1812-28-H) update Oscor Inc. Issues Recall of TB Temporary Bipolar Pacing Lead (Unshrouded 2 mm Pins Models)
Medical Report
(SG-1811-27-H) Oscor Inc. Issues Recall of TB Temporary Bipolar Pacing Lead (Unshrouded 2 mm Pins Models)
Medical Report
A Phase III, Multicenter, Randomized, parallel-group study to asses the efficacy and saftey of double-blind pasireotide LAR 40 mg and pasireotide LAR 60 mg versus open lable octreotide LAR or lanreotide ATG in patients with inadequately controlled acromegaly.
Drug Clinical Trial
Pagination
First page
« First
Previous page
‹ Previous
…
الصفحة
19
الصفحة
20
الصفحة
21
الصفحة
22
Current page
23
الصفحة
24
الصفحة
25
الصفحة
26
الصفحة
27
…
Next page
Next ›
Last page
Last »